1 2 3 4 5

Home  »  Medlab Updates

PathCare Nigeria Joins Synlab - Nov. 2017

LAGOS, Nov 24 (Reuters) - Europe's largest lab operator Synlab has bought a majority stake in Nigerian diagnostic company PathCare Nigeria to try to tap into an underserved market for medical tests in Africa's most populous country, it said on Friday.

Nigerian lab operators, providing standard blood and urine tests as well as other medical and veterinary diagnostic services, have been attracting foreign interest to consolidate a sector dominated by family-owned businesses.

Its Chairman, Dr Richard Ajayi, who talked about the past, present and future of the firm, said PathCare has been in existence for more than a decade. “It came into existence when the health care of the country needed urgent need for its medical needs.

As the only internationally (ISO 15189) accredited pathology laboratory in Nigeria, PathCare is constantly innovating and upgrading to provide its customers accurate and reliable results of international standards.

The German lab chain -- which operates in more than 30 countries mainly in Europe -- has previously said it was looking at selective acquisitions in its current and in new markets.

PathCare Nigeria operates six laboratories and 21 blood collection points across Nigeria and is engaged in a public private partnership with the leading public hospital in Lagos.

Dr. Richard Ajayi, said the company bought back a 26 percent stake held by PathCare South Africa, its former parent company this year before the Synlab deal.

PathCare partnered with Synlab to accelerate growth in Nigeria, Ajayi told Reuters, adding that the local company will be rebranded over the next six months.

"PathCare Nigeria's customers will benefit from an enhanced test portfolio drawing from the breadth and depth of Synlab's international expertise," he said in a statement.

At the event, was also Dr. Rosmary Keatley, the MD of Medlab Ghana Ltd , a member of Synlab,  Dr Pamela Ajayi , PathCare Managing Director.